Valuation Alfresa Holdings Corporation

Stocks

Market Closed - Japan Exchange 09:30:00 21/08/2026 +03			5-day change	1st Jan Change
2,337.00 ^JPY	+0.73%		+4.75%	-3.87%

07-01	Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation	CI
06-22	Alfresa Holdings Corporation(TSE:2784) dropped from S&P Japan Mid Cap 100	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	343,826	343,217	415,318	383,847	459,384	409,941	-	-
Change	-	-0.18%	21.01%	-7.58%	19.68%	-10.76%	-	-
Enterprise Value (EV)	168,429	186,950	236,499	242,307	301,938	409,941	409,941	409,941
Change	-	11%	26.5%	2.46%	24.61%	35.77%	0%	0%
P/E	11.1x	13.3x	14.4x	14.3x	11x	17.8x	14.8x	15.5x
PBR	0.73x	0.7x	0.87x	0.8x	0.91x	0.82x	0.78x	0.78x
PEG	-	-0.8x	0.7x	-3.34x	0.2x	-0.4x	0.7x	-3.3x
Capitalization / Revenue	0.13x	0.13x	0.15x	0.13x	0.15x	0.13x	0.12x	0.12x
EV / Revenue	0x	0x	0x	0x	0x	0.13x	0.12x	0.12x
EV / EBITDA	0x	0x	0x	0x	0x	8.3x	8.06x	7.81x
EV / EBIT	0x	0x	0x	0x	0x	11.9x	11x	10.8x
EV / FCF	0x	-0x	0x	-0x	0x	19.5x	25.1x	34.2x
FCF Yield	11.3%	-2.17%	17.4%	-4.12%	6.5%	5.12%	3.99%	2.93%
Dividend per Share ²	54	57	70	63	68	71	79	85
Rate of return	3.18%	3.36%	3.15%	2.98%	2.69%	3.04%	3.38%	3.64%
EPS ²	153.6	127.4	154.1	147.5	229.6	131.1	158	150.6
Distribution rate	35.2%	44.7%	45.4%	42.7%	29.6%	54.2%	50%	56.5%
Net sales ¹	2,585,643	2,696,069	2,858,500	2,961,051	3,104,064	3,188,539	3,279,596	3,340,075
EBITDA ¹	41,915	43,450	51,974	58,607	51,212	49,400	50,836	52,514
EBIT ¹	29,091	30,148	38,460	38,080	36,164	34,453	37,402	38,069
Net income ¹	32,182	25,786	29,558	27,389	41,746	23,486	27,351	26,886
Net Debt	-175,397	-156,267	-178,819	-141,540	-157,446	-	-	-
Reference price ²	1,699.00	1,696.00	2,222.50	2,111.50	2,528.00	2,337.00	2,337.00	2,337.00
Nbr of stocks (in thousands)	202,370	202,369	186,870	181,789	181,719	175,413	-	-
Announcement Date	5/16/22 A	5/15/23 A	5/14/24 A	5/15/25 A	5/15/26 A	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ALFRESA HOLDINGS CORPORATION	17.7x	-	-	3.06%	2.56B
ABBOTT LABORATORIES	32.74x	4.4x	17.04x	2.25%	198B
MEDTRONIC PLC	20.92x	3.59x	12.63x	3.22%	118B
CENCORA, INC.	17.23x	0.2x	12.62x	0.76%	60.05B
HOYA CORPORATION	30.79x	7.66x	19.56x	1.29%	53.18B
BECTON, DICKINSON AND COMPANY	36.16x	3.47x	11.9x	2.09%	51.11B
DEXCOM, INC.	36.16x	6.36x	19.98x	-.--%	34.05B
MEDLINE INC.	42.76x	1.23x	11.27x	0.18%	28.58B
WEST PHARMACEUTICAL SERVICES, INC.	41.25x	7.23x	25.94x	0.26%	24.9B
STERIS PLC	25.39x	3.82x	13.43x	1.13%	22.98B
Average	30.11x	4.22x	16.04x	1.42%	59.31B
Weighted average by Cap.	29.62x	4.08x	15.61x	1.84%